Search

You searched for "BCG."

23 results found

Upper tract urothelial carcinoma following cystectomy

3 May 2022 | Jay Khastgir | URO - Urologic Oncology

Metachronous upper tract urothelial cancer (UTUC) is encountered in about 5% of patients after radical cystectomy (RC) with a median time to diagnosis of 24-36 months after RC, and most are asymptomatic and detected by surveillance protocols. In this multivariate...

An algorithm for the management of haemorrhagic cystitis

1 September 2015 | Sudhanshu Garg, Suresh Ganta, Jay Khastgir | URO - Endourology & Stones, URO - Functional / Reconstructive Urology, URO - Urologic Oncology

Haemorrhagic cystitis (HC) can be one of the most difficult conditions to treat in urological practice. It is characterised by intractable bleeding from the bladder and may be acute or chronic. The most frequently reported causal factors are radiotherapy (RT)...

Urologic complications of radiotherapy

1 July 2014 | Steve McCombie, Dickon Hayne, Nick Rukin | URO - Urologic Oncology

Case 1 1. What machine is seen in the picture? 2. What is the standard dose schedule for radiotherapy for prostate cancer? 3. What are the complications of radiotherapy? Case 2 1. How does haemorrhagic cystitis develop? 2. What are...

Upper urinary tract urothelial cell carcinoma

7 January 2021 | Angus C-O Luk, Alexandra Miller | URO - Urologic Oncology

Case 1 A 64-year-old man presents to the haematuria clinic with visible haematuria, on a background of a 40 pack-year smoking history and family history of bowel cancer in his sister at the age of 48. A CT was performed...

Should it be a mandatory requirement for medical students to receive the COVID-19 vaccine to attend clinical attachments?

11 August 2021 | Charles O’Donovan | URO - Covid-19

The vast majority of medical students have positive attitudes towards the COVID-19 vaccine for themselves and patients, however, what about the small inevitable minority who resist it? Should they be prevented from attending clinical attachments in the NHS? It is...

REPORT: Urology News Patient Engagement Evenings

6 November 2020 | Jennifer Fallon

Towards the end of 2019 the team at Urology News began making plans for our first event. An educational study day focusing on how to improve patient engagement in urology was to be held in Edinburgh at the end of...

Redundant! Do urological surgeons have a future in treating urological cancers? RSM Urology Section Meeting

4 March 2024 | Ross Warner, Ben Lamb | URO - Urologic Oncology

December 2023 marked the latest RSM Urology Section event. Alongside the Winter Short Papers Prize presentations, the theme of the day was major urological cancers and the role of the urologist in patient management within the multidisciplinary team (MDT). We...

Challenges of upper tract urothelial carcinoma

1 July 2022 | James C Pearson, Musaab Hamdoon, Suresh Venugopal | URO - Urologic Oncology

Upper tract uroepithelial carcinoma (UTUC) is a fairly common disease which traditionally had poorer outcomes compared to bladder cancer. This is due to various factors leading to delayed diagnosis and problems in risk stratification. Continuing efforts have focused on early...

Endoscopic management of upper tract urothelial carcinoma

1 January 2014 | Miles Goldstraw, Eleanor Ray, Susie Longhorn, Timothy Philp, Simon Choong, Daron Smith | URO - Urologic Oncology

Upper tract urothelial carcinoma (UTUC) is a rare disease accounting for 5-10% of all urothelial carcinomas and has an annual incidence in Western countries of 1-2 per 100,000 [1,2]. It occurs more commonly in the pelvicalyceal system as opposed to...

Non-urothelial bladder malignancies

3 May 2024 | Arvinda Chippagiri, Christopher Gallegos, Edward Jefferies | URO - Urologic Oncology

Case 1 An 80-year-old gentleman presented with a history of visible haematuria and recurrent urinary tract infections (UTIs). He has been performing intermittent self catheterisation (ISC) for detrusor underactivity for over 20 years. A flexible cystoscopy showed these appearances of...

Urinary biomarkers for surveillance of non-muscle invasive bladder cancer

1 May 2019 | Ibrahim Jubber, Karl H Pang, James WF Catto | URO - Basic Science Research, URO - Urologic Oncology

Bladder cancer (BC) is the ninth most common cancer worldwide with a yearly incidence of approximately 430,000 cases. There is a male predominance and it is the seventh most common cancer in men worldwide [1]. Non-muscle invasive bladder cancer (NMIBC)...

«
1
2 (current)